Eric K. Brandt

Executive Vice President and Chief Financial Officer

Eric Brandt serves as Broadcom's Executive Vice President and Chief Financial Officer. In this role, he is responsible for managing Broadcom's financial, information technology and corporate services organizations. For the last four years, he was named one of the "Best CFOs in America — Semiconductors" by Institutional Investor and was #1 in the 2011, 2013 and 2014 rankings. In addition, he was honored for "2012 Best Investor Relations by a CFO" and "2013 Grand Prix for Best Overall Investor Relations Program" (all industries from $2B - $20B market cap) and received the "2013 Sector Award for Technology" (mid and small cap) by Investor Relations.

Mr. Brandt joined Broadcom in 2007 after serving as President and Chief Executive Officer of Avanir Pharmaceuticals, a developer of novel therapeutic products for the treatment of chronic disease. Prior to joining Avanir, he served as Executive Vice President of Finance and Technical Operations and Chief Financial Officer of Allergan Inc., a global specialty pharmaceutical and medical device company. While at Allergan, Mr. Brandt was twice named one of the "Best CFOs in America — #1 in Specialty Pharmaceuticals" by Institutional Investor. Mr. Brandt joined Allergan after nearly a decade with The Boston Consulting Group (BCG), a global business consulting firm. He served as Vice President and Partner and as a senior member of the firm's health care practice. While at BCG he also led the North American operations practice.

Mr. Brandt currently serves on the boards of Broadcom Foundation, Dentsply International, Inc. and Lam Research, Inc. He received a B.S. in Chemical Engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.